HSBC Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Buy |
57,898
+32,899
| +132% | +$570K | ﹤0.01% | 1391 |
|
|
2025
Q1 | $552K | Sell |
24,999
-102,829
| -80% | -$2.27M | ﹤0.01% | 1599 |
|
|
2024
Q4 | $4.08M | Buy |
127,828
+9,341
| +8% | +$298K | ﹤0.01% | 960 |
|
|
2024
Q3 | $3.41M | Buy |
118,487
+83,563
| +239% | +$2.41M | ﹤0.01% | 995 |
|
|
2024
Q2 | $1.34M | Sell |
34,924
-63,626
| -65% | -$2.43M | ﹤0.01% | 1261 |
|
|
2024
Q1 | $5.79M | Buy |
+98,550
| New | +$5.79M | ﹤0.01% | 885 |
|
|
2023
Q4 | – | Sell |
-50,544
| Closed | -$1.96M | – | 2225 |
|
|
2023
Q3 | $1.96M | Buy |
+50,544
| New | +$1.96M | ﹤0.01% | 1123 |
|
|
2023
Q2 | – | Sell |
-17,530
| Closed | -$1.17M | – | 2104 |
|
|
2023
Q1 | $1.17M | Buy |
+17,530
| New | +$1.17M | ﹤0.01% | 1346 |
|
|
2022
Q3 | – | Sell |
-10,887
| Closed | -$497K | – | 2454 |
|
|
2022
Q2 | $497K | Buy |
10,887
+996
| +10% | +$45.5K | ﹤0.01% | 1953 |
|
|
2022
Q1 | $504K | Buy |
9,891
+5,290
| +115% | +$270K | ﹤0.01% | 2067 |
|
|
2021
Q4 | $219K | Buy |
+4,601
| New | +$219K | ﹤0.01% | 2506 |
|
|
2021
Q3 | – | Sell |
-3,701
| Closed | -$236K | – | 2494 |
|
|
2021
Q2 | $236K | Buy |
+3,701
| New | +$236K | ﹤0.01% | 2246 |
|
|
2020
Q3 | – | Sell |
-7,580
| Closed | -$248K | – | 2251 |
|
|
2020
Q2 | $248K | Buy |
+7,580
| New | +$248K | ﹤0.01% | 1852 |
|